RNCOS

Chinese Reusable Pen Market to Surge at Double Digit

Press Release   •   Jul 03, 2013 12:46 IST

As per the new research report by RNCOS, “Global Insulin Delivery Devices Market Forecast to 2017”, reusable insulin pens are growing in the Chinese market, primarily due to consumer preferences towards convenient delivery mechanisms. Currently over 85% of insulin taking diabetic population in China uses reusable insulin pen and insulin cartridge for their therapy.

This market is set for an escalated growth owing to the growth in the insulin market. There is a huge unmet demand supply gap in the region. According to the IDF Diabetes Atlas, 5th Edition, more than 92 Million people suffer from diabetes in China of which, nearly 52 Million are undiagnosed. Of the 40 Million diagnosed diabetics, nearly 10 Million require insulin therapy, but due to the distributed nature of the diabetic population, nearly 50% of the insulin needing population that mostly lives in rural regions, currently doesn’t get the therapy. The Chinese government is actively working towards reducing this gap by promoting the insulin manufacturing units in the region. Reduction in demand supply gap will result in a subsequent increase in the number of insulin users thereby increasing the overall market for insulin delivery systems, specifically reusable insulin pens due to consumer preference, in the region.

The report provides an in-depth research and rational analysis of the current status and future prospect of the insulin delivery system market. The study presents a global picture about prevalence of diabetes and the overall market for insulin delivery systems. It includes a geographical analysis of insulin delivery systems in key diabetic countries. The research further covers the market for main insulin delivery systems along with their current and future projections.

Our study leads to the proposition that innovation has huge scope in this field and we have advertently elaborated some of the emerging insulin delivery devices. Finally, an analysis of the leading market players provides a holistic understanding to the reader. Players covered include Novo Nordisk, Eli Lilly, Sanofi-Aventis, Medtronic, Roche, Becton Dickinson and Company who together account for more than 90% of the global market.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM494.htm

Some of our Related Reports are:

- US Non-Invasive Prenatal Diagnostics - Market Insight (http://www.rncos.com/Report/IM450.htm)
- Genetic Testing Market Outlook to 2017 (http://www.rncos.com/Report/IM492.htm)
- Analysis of Coronary Stent in US (http://www.rncos.com/Report/IM489.htm)
- US Healthcare IT Market Outlook to 2017 (http://www.rncos.com/Report/IM487.htm)
- US Personalized Cancer Genome Sequencing Market (http://www.rncos.com/Report/IM453.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.